nach oben

Head and Neck Pathology

Erschienen in:

01.12.2024 | Review

Unraveling the Genetic Web: H-Ras Expression and Mutation in Oral Squamous Cell Carcinoma—A Systematic Review

verfasst von: Priya Devi, Ruby Dwivedi, Roshna Sankar, Ayushi Jain, Sameer Gupta, Shalini Gupta

Erschienen in: Head and Neck Pathology | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Abstract

Background

Oral squamous cell carcinoma (OSCC) is a commonly occurring malignancy with complex genetic alterations contributing to its development. The H-Ras, a proto-oncogene, becomes an oncogene when mutated and has been implicated in various cancers. This systematic review aims to research to what extent H-Ras expression and mutation contribute to the development and progression of OSCC, and how does this molecular alteration impacts the clinical characteristics and prognosis in patients with OSCC.

Methods

A thorough electronic scientific literature search was carried out in PUBMED, SCOPUS, and GOOGLE SCHOLAR databases from 2007 to 2021. The search strategy yielded 120 articles. Following aggregation and filtering all results through our inclusion and exclusion criteria total 9 articles were included in our literature review. It has also been registered with PROSPERO (CRD42023485202).

Results

It was found that mutations in the Ras gene commonly reported in hotspots at codons 12, 13, and 61 resulting in the activation of downstream signaling pathways causing abnormal and uncontrolled cell growth. This systematic review has shown an increased prevalence of H-Ras mutation in well-differentiated OSCC and also the prevalence of H-Ras mutation in individuals engaging in multiple risk behaviors, particularly chewing tobacco, demonstrated a significant association with a higher prevalence of H-Ras positivity.

Conclusion

This review sheds light on the prevalence of H-Ras mutations, their association with clinical characteristics, and their potential implications for OSCC prognosis. It also enhances our comprehension of the molecular mechanisms that underlie OSCC and paves the way for further research into targeted treatments based on H-Ras alterations.

Johnson NW, Jayasekara P, Amarasinghe AA (2000) Squamous cell carcinoma and precursor lesions of the oral cavity: epidemiology and etiology. Periodontol 2011(57):19–37

Chi AC, Day TA, Neville BW (2015) Oral cavity and oropharyngeal squamous cell carcinoma-an update. CA Canc J Clin 65:401–421. https://doi.org/10.3322/caac.21293CrossRef

Albuquerque R, Lopez-Lopez J, Mari-Roig A, Jane-Salas E, Rosel Lo-Llabres X, Santos JR (2011) Oral tongue squamous cell carcinoma (OT SCC): alcohol and tobacco consumption versus non-consumption. A study in a Portuguese population. Braz Dent J 22:517–521CrossRefPubMed

Moyses RA, López RV, Cury PM, Siqueira SA, Curioni OA, Gois Filho JF et al (2013) Significant differences in demographic, clinical, and pathological features in relation to smoking and alcohol consumption among 1,633 head and neck cancer patients. Clinics (Sao Paulo) 68:738–744CrossRefPubMed

Ribeiro AC, Silva AR, Simonato LE, Salzedas LM, Sundefeld ML, Soubhia AM (2009) Clinical and histopathological analysis of oral squamous cell carcinoma in young people: a descriptive study in Bra zillions. Br J Oral Maxillofac Surg 47:95–98CrossRefPubMed

Argiris A, Eng C (2003) Epidemiology, staging, and screening of head and neck cancer. Cancer Treat Res 114:15–60CrossRefPubMed

Majchrzak E, Szybiak B, Wegner A, Pienkowski P, Pazdrowski J, Luczewski L et al (2014) Oral cavity and oropharyngeal squamous cell carcinoma in young adults: a review of the literature. Radiol Oncol 48:1–10CrossRefPubMedPubMedCentral

Toner M, O’Regan EM (2009) Head and neck squamous cell carcinoma in the young: a spectrum or a distinct group? Part 1. Head Neck Pathol 3:246–248CrossRefPubMedPubMedCentral

Falaki F, Dalirsani Z, Pakfetrat A, Falaki A, Saghravanian N, Nosratzehi T et al (2011) Clinical and histopathological analysis of oral squamous cell carcinoma of young patients in Mashhad, Iran: a retrospective study and review of literature. Med Oral Patol Oral Cir Bucal 16:e473–e477CrossRefPubMed

10.

Troeltzch M, Knösel T, Eichinger C, Probst F, Troeltzsch M, Woodlock T et al (2014) Clinicopathologic features of oral squamous cell carcinoma: do they vary in different age groups? J Oral Maxillofac Surg 72:1291–1300CrossRef

11.

Patel SC, Carpenter WR, Tyree S, Couch ME, Weissler M, Hack man T et al (2011) Increasing incidence of oral tongue squamous cell carcinoma in young white women, age 18 to 44 years. J Clin Oncol 29:1488–1494CrossRefPubMed

12.

Kaminagakura E, Villa LL, Andreoli MA, Sobrinho JS, Vartanian JG, Soares FA et al (2012) High-risk human papillomavirus in oral squamous cell carcinoma of young patients. Int J Cancer 130(1726):32

13.

Colevas AD, Yom SS, Pfister DG et al (2018) NCCN guidelines insights: head and neck cancers, version 1.2018. J Natl Compr Canc Netw 16:479–490. https://doi.org/10.6004/jnccn.2018.0026CrossRefPubMed

14.

Krishna A, Singh S, Kumar V et al (2015) Molecular concept in human oral cancer. Natl J Maxillofac Surg 6(1):9–15. https://doi.org/10.4103/0975-5950.168235CrossRefPubMedPubMedCentral

15.

Neville BW, Damm DD, Allen CM et al (2009) Oral and maxillofacial pathology. Elsevier, St. Louis

16.

Stransky N, Egloff AM, Tward AD et al (2011) The mutational landscape of head and neck squamous cell carcinoma. Science 333:1157–1160. https://doi.org/10.1126/science.1208130ADSCrossRefPubMedPubMedCentral

17.

Parada LF, Tabin CJ, Shih C et al (1982) Bladder carcinoma oncogene is homologue of Harvey sarcoma virus ras gene. Nature 297:474–478. https://doi.org/10.1038/297474a0ADSCrossRefPubMed

18.

Young A, Lou D, McCormick F (2013) Oncogenic and wild-type ras play divergent roles in the regulation of mitogen-activated protein kinase signaling. Cancer Discov 3:112–123CrossRefPubMed

19.

Nakadate Y, Kodera Y, Kitamura Y, Shirasawa S, Tachibana T, Tamura T et al (2014) KRAS mutation confers resistance to antibody-dependent cellular cytotoxicity of cetuximab against human colorectal cancer cells. Int J Cancer 134:2146–2155CrossRefPubMed

20.

Grabocka E, Bar-Sagi D (2016) Mutant KRAS enhances tumor cell fitness by upregulating stress granules. Cell 167:1803–1813CrossRefPubMedPubMedCentral

21.

Shields JM, Pruitt K, McFall A, Shaub A, Der CJ (2000) Understanding ras: ‘It ain’t over ‘til it’s over.’ Trends Cell Biol 10:147–154CrossRefPubMed

22.

Krishna A, Singh S, Kumar V, Pal US (2015) Molecular concept in human oral cancer. Natl J Maxillofac Surg 6:9–15CrossRefPubMedPubMedCentral

23.

Repasky GA, Chenette EJ, Der CJ (2004) Renewing the conspiracy theory debate: does Raf function alone to mediate ras oncogenesis? Trends Cell Biol 14:639–647. https://doi.org/10.1016/j.tcb.2004.09.014CrossRefPubMed

24.

Sathyan KM, Nalinakumari KR, Kannan S (2007) H-Ras mutation modulates the expression of major cell cycle regulatory proteins and disease prognosis in oral carcinoma. Modern Pathol. https://doi.org/10.1038/modpathol.3800948CrossRef

25.

Murugan AK, Nguyen TH et al (2009) Detection of two novel mutations and relatively high incidence of H-RAS mutations in Vietnamese oral cancer. Oral Oncol. https://doi.org/10.1016/j.oraloncology.2009.05.638CrossRefPubMed

26.

Koumaki D, Kostakis G, Koumaki V et al (2012) Novel mutations of the HRAS gene and absence of hotspot mutations of the BRAF genes in oral squamous cell carcinoma in a Greek population. Oncol Rep 27:1555–1560. https://doi.org/10.3892/or.2012.1653CrossRefPubMed

27.

Chiosea SI, Grandis JR, Lui VWY et al (2013) PIK3CA, HRAS, and PTEN in human papillomavirus positive oropharyngeal squamous cell carcinoma. BMC Cancer 13:602. https://doi.org/10.1186/1471-2407-13-602CrossRefPubMedPubMedCentral

28.

Chang YS, Hsu HT, Ko YC et al (2014) Combined mutational analysis of RAS, BRAF, PIK3CA, and TP53 genes in Taiwanese patients with oral squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol. https://doi.org/10.1016/j.oooo.2014.03.016CrossRefPubMed

29.

Roodi AM, Allameh A, Harirchi I et al (2016) Studies on the contribution of Cox-2 expression in the progression of oral squamous cell carcinoma and H-Ras activation. Pathol Oncol Res. https://doi.org/10.1007/s12253-016-0114-1CrossRef

30.

Krishna A, Singh S, Singh V et al (2018) Does Harvey-Ras gene expression lead to oral squamous cell carcinoma? A clinicopathological aspect. J Oral Maxillofacial Pathol. 22:1–65. https://doi.org/10.4103/jomfp.JOMFP_246_17MathSciNetCrossRef

31.

Batta N, Pandey M (2019) Mutational spectrum of tobacco associated oral squamous carcinoma and its therapeutic significance. World J Surg Oncol 17:198. https://doi.org/10.1186/s12957-019-1741-2CrossRefPubMedPubMedCentral

32.

Uchibori M, Osawa Y, Ishii Y et al (2021) Analysis of HRAS mutations in Japanese patients with oral squamous cell carcinoma. Adv Oral Maxillofacial Surg. 1:100021. https://doi.org/10.1016/j.adoms.2021.100021CrossRef

33.

Molinolo AA, Amornphimoltham P, Squarize CH, Castilho RM, Patel V, Gutkind SJ (2009) Dysregulated molecular networks in head and neck carcinogenesis. Oral Oncol 45(4–5):324–334CrossRefPubMed

34.

Shaw RJ, Cantley LC (2006) Ras, PI(3)K and mTOR signaling controls tumor cell growth. Nature 441(7092):424–430ADSCrossRefPubMed

35.

Chang F, Steelman LS, Shelton JG et al (2003) Regulation of cell cycle progression and apoptosis by the Ras/Raf/MEK/ERK pathway (Review). Int J Oncol 22:469–480. https://doi.org/10.3892/ijo.22.3.469CrossRefPubMed

36.

Barbacid M (1987) RAS genes. Annu Rev Biochem 56:779–827. https://doi.org/10.1146/annurev.bi.56.070187.004023CrossRefPubMed

37.

Paterson IC, Eveson JW, Prime SS (1996) Molecular changes in oral cancer may reflect aetiology and ethnic origin. Eur J Cancer B Oral oncol 32B(3):150–153CrossRefPubMed

38.

Lyu H, Li M, Jiang Z et al (2019) Correlate the TP53 mutation and the HRAS mutation with immune signatures in head and neck squamous cell cancer. Comput Struct Biotechnol J 17:1020–1030. https://doi.org/10.1016/j.csbj.2019.07.009CrossRefPubMedPubMedCentral

39.

Shaw RJ, Cantley LC (2006) Ras, PI(3)K and mTOR signalling controls tumor cell growth. Nature 441:424–430. https://doi.org/10.1038/nature04869ADSCrossRefPubMed

40.

Muñoz-Maldonado C, Zimmer Y, Medová M (2019) A comparative analysis of individual RAS mutations in cancer biology. Front Oncol 9:1088. https://doi.org/10.3389/fonc.2019.01088CrossRefPubMedPubMedCentral

41.

Terrell EM, Morrison DK (2019) Ras-mediated activation of the raf family kinases. Cold Spring Harb Perspect Med 9:033746. https://doi.org/10.1101/cshperspect.a033746CrossRef

42.

Das N, Majumder J, DasGupta UB (2000) Ras gene mutations in oral cancer in eastern India. Oral Oncol 36:76–80. https://doi.org/10.1016/S1368-8375(99)00058-5CrossRefPubMed

43.

Munirajan AK, Mohanprasad BK, Shanmugam G et al (1998) Detection of a rare point mutation at codon 59 and relatively high incidence of H-ras mutation in Indian oral cancer. Int J Oncol 13:971–974. https://doi.org/10.3892/ijo.13.5.971CrossRefPubMed

44.

Saranath D, Chang SE, Bhoite LT et al (1991) High frequency mutation in codons 12 and 61 of H-ras oncogene in chewing tobacco-related human oral carcinoma in India. Br J Cancer 63:573–578. https://doi.org/10.1038/bjc.1991.133CrossRefPubMedPubMedCentral

45.

Sanchez-Montenegro C, Vilanova-Sanchez A, Barrena-Delfa S et al (2017) Costello syndrome and umbilical ligament rhabdomyosarcoma in two pediatric patients: case reports and review of the literature. Case Rep Genet 2017:1587610. https://doi.org/10.1155/2017/1587610CrossRefPubMedPubMedCentral

46.

The Catalogue of Somatic Mutations in Cancer. https://scholar.google.com/scholar?q=intitle:The%20Catalogue%20of%20Somatic%20Mutations%20in%20Cancer

47.

Cutilli T, Papola F, Di Emidio P, Corbacelli A (1998) P53 tumor suppressor protein and H-RAS oncogene in maxillofacial tumors: Immunohistochemical and genetic investigation, induction chemotherapy response and prognosis evaluation. J Chemother 10:411–417. https://doi.org/10.1179/joc.1998.10.5.411CrossRefPubMed

48.

McDonald JS, Jones H, Pavelic ZP et al (1994) Immunohistochemical detection of the H-ras, K-ras, and N-ras oncogenes in squamous cell carcinoma of the head and neck. J Oral Pathol Med 23:342–346. https://doi.org/10.1111/j.1600-0714.1994.tb00073.xCrossRefPubMed

49.

Winston JT, Coats SR, Wang YZ et al (1996) Regulation of the cell cycle machinery by oncogenic ras. Oncogene 12:127–134PubMed

50.

Jayasurya R, Sathyan KM, Lakshminarayanan K et al (2005) Phenotypic alterations in Rb pathway have more prognostic influence than p53 pathway proteins in oral carcinoma. Mod Pathol 18:1056–1066. https://doi.org/10.1038/modpathol.3800387CrossRefPubMed

51.

Williams JP, Stewart T, Li B et al (2006) The retinoblastoma protein is required for Ras-induced oncogenic transformation. Mol Cell Biol 26:1170–1182. https://doi.org/10.1128/MCB.26.4.1170-1182.2006CrossRefPubMedPubMedCentral

52.

Lee KW, Kim MS, Kang NJ et al (2006) H-ras selectively up-regulates MMP-9 and COX-2 through activation of ERK1/2 and NF-kappaB: an implication for invasive phenotype in rat liver epithelial cells. Int J Cancer 119:1775. https://doi.org/10.1002/ijc.22056CrossRef

53.

Zarbl H, Sukumar S, Arthur AV, Martin-Zanca D, Barbacid M (1985) Direct mutagenesis of of Ha-ras-1 oncogenes by N-nitroso-N-methylurea during initiation of mammary carcinogenesis in rats. Nature 315(6018):382–385ADSCrossRefPubMed

54.

Quintanilla M, Brown K, Ramsden M, Balmain A (1986) Carcinogen specific mutation and amplification of Ha-ras during mouse skin carcinogenesis. Nature 322(6074):78–80ADSCrossRefPubMed

55.

Chang KW, Sarraj S, Lin SC et al (2000) P53 expression, p53 and Ha-ras mutation and telomerase activation during nitrosamine-mediated hamster pouch carcinogenesis. Carcinogenesis 21:1441–1451. https://doi.org/10.1093/carcin/21.5.441CrossRefPubMed

56.

Xu J, Gimenez-Conti IB, Cunningham JE et al (1998) Alterations of p53, cyclin D1, Rb, and H-ras in human oral carcinomas related to tobacco use. Cancer 1998:204–212CrossRef

57.

Squamous cell carcinoma of head and neck. https://clinicaltrials.gov/

58.

Ho AL, Brana I, Haddad R et al (2021) Tipifarnib in head and neck squamous cell carcinoma with HRAS mutations. J Clin Oncol 10:1856–1864. https://doi.org/10.1200/JCO.20.02903CrossRef

59.

Coleman N, Marcelo KL, Hopkins JF et al (2023) HRAS mutations define a distinct subgroup in head and neck squamous cell carcinoma. JCO Precision Oncol. https://doi.org/10.1200/PO.22.00211CrossRef

60.

Khan I, Spencer-Smith R, O’Bryan JP et al (2018) Targeting the α4-α5 dimerization interface of K-RAS inhibits tumor formation in vivo. Oncogene 38:2984–2993. https://doi.org/10.1038/s41388-018-0636-yCrossRefPubMedPubMedCentral

61.

Fang Z, Marshall CB, Nishikawa T et al (2018) Inhibition of K-RAS4B by a unique mechanism of action: stabilizing membrane-dependent occlusion of the effector-binding site. Cell Chem Biol 25:1327–1336. https://doi.org/10.1016/j.chembiol.2018.07.009CrossRefPubMed

Titel: Unraveling the Genetic Web: H-Ras Expression and Mutation in Oral Squamous Cell Carcinoma—A Systematic Review
verfasst von: Priya Devi
Ruby Dwivedi
Roshna Sankar
Ayushi Jain
Sameer Gupta
Shalini Gupta
Publikationsdatum: 01.12.2024
Verlag: Springer US
Erschienen in: Head and Neck Pathology / Ausgabe 1/2024
Elektronische ISSN: 1936-0568
DOI: https://doi.org/10.1007/s12105-024-01623-8

Springer Medizin

Unraveling the Genetic Web: H-Ras Expression and Mutation in Oral Squamous Cell Carcinoma—A Systematic Review

Abstract

Background

Methods

Results

Conclusion

Neu im Fachgebiet Pathologie

Molekularpathologische Untersuchungen im Wandel der Zeit

Vergleichende Pathologie in der onkologischen Forschung

Gastrointestinale Stromatumoren

Personalisierte Medizin in der Onkologie

Springer Medizin

Abstract

Background

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2024

Enigma of Acantholytic and Clear Cell Changes in Oral Squamous Cell Carcinoma

A Comparison of Clear Cell Sarcoma to Jaw and Salivary Tumors Bearing EWS Fusions

Fungal Otitis Externa (Otomycosis) Associated with Aspergillus Flavus: A Case Image

BRAF p.V600E Mutational Status Does Not Correlate with Biological Behavior in Conventional Ameloblastomas: A Disease-Free Survival Analysis

Sinonasal Differentiated Papillary NUT Carcinoma

Primary Oral Mixed Neuroendocrine–Non-neuroendocrine Neoplasm (MiNEN): A Rare Case Report and Review of the Literature

Neu im Fachgebiet Pathologie

Molekularpathologische Untersuchungen im Wandel der Zeit

Vergleichende Pathologie in der onkologischen Forschung

Gastrointestinale Stromatumoren

Personalisierte Medizin in der Onkologie